Early phase drug discovery

Friday, May 3, 2019: 5:30 PM-7:00 PM
Room: 710 (Palais des congres de Montreal)
5:30 PM
209.179
179 An Open Label and Double Blind Randomized Placebo Controlled Pilot Study of L1-79 [D,L Alpha-Methyl-Para-Tyrosine (DL-AMPT)] for the Treatment of the Core Symptoms of Autism Spectrum Disorder (ASD) in Adolescent and Young Adult Males
J. Rothman P. Halas E. J. Bartky T. Fischer J. T. Megerian
See more of: Early Phase Drug Discovery
<< Previous Panel | Next Panel >>